Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review

  • ID: 4286385
  • SWOT Analysis
  • 51 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Eli Lilly and Co
  • GE Healthcare LLC
  • Ignyta Inc
  • Lantern Pharma Inc
  • Piramal Enterprises Ltd
  • Syapse Inc
  • MORE
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi’s, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping and NAV4694 for Alzhemier’s Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc Key Recent Developments

Aug 17, 2018 Navidea Biopharmaceuticals announces results of the Annual Shareholder Meeting
Aug 16, 2018 Navidea Biopharmaceuticals announces details of 2018 Annual General Meeting
Aug 15, 2018 Navidea Biopharmaceuticals receives noncompliance notice from NYSE American
Aug 08, 2018 Navidea Biopharmaceuticals reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Eli Lilly and Co
  • GE Healthcare LLC
  • Ignyta Inc
  • Lantern Pharma Inc
  • Piramal Enterprises Ltd
  • Syapse Inc
  • MORE
Section 1 - About the Company
Navidea Biopharmaceuticals Inc - Key Facts
Navidea Biopharmaceuticals Inc - Key Employees
Navidea Biopharmaceuticals Inc - Key Employee Biographies
Navidea Biopharmaceuticals Inc - Major Products and Services
Navidea Biopharmaceuticals Inc - History
Navidea Biopharmaceuticals Inc - Company Statement
Navidea Biopharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Navidea Biopharmaceuticals Inc -
Business Description

R&D Overview
Navidea Biopharmaceuticals Inc - Corporate Strategy
Navidea Biopharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Navidea Biopharmaceuticals Inc - Strengths
Navidea Biopharmaceuticals Inc - Weaknesses
Navidea Biopharmaceuticals Inc - Opportunities
Navidea Biopharmaceuticals Inc - Threats
Navidea Biopharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s, Lifesciences Financial Deals and Alliances
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Navidea Biopharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s
Recent Developments

Aug 17, 2018: Navidea Biopharmaceuticals announces results of the Annual Shareholder Meeting
Aug 16, 2018: Navidea Biopharmaceuticals announces details of 2018 Annual General Meeting
Aug 15, 2018: Navidea Biopharmaceuticals receives noncompliance notice from NYSE American
Aug 08, 2018: Navidea Biopharmaceuticals reports second quarter 2018 financial results
Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results
Nov 01, 2017: Navidea to Present Late-Breaking Abstract at American College of Rheumatology Annual Meeting
Aug 08, 2017: Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results
May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results
Apr 25, 2017: Navidea Biopharmaceuticals Invited to Present Data at Two Major Upcoming Conferences

Section 6 –
Appendix

Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Navidea Biopharmaceuticals Inc, Key Facts
Navidea Biopharmaceuticals Inc, Key Employees
Navidea Biopharmaceuticals Inc, Key Employee Biographies
Navidea Biopharmaceuticals Inc, Major Products and Services
Navidea Biopharmaceuticals Inc, History
Navidea Biopharmaceuticals Inc, Subsidiaries
Navidea Biopharmaceuticals Inc, Key Competitors
Navidea Biopharmaceuticals Inc, Ratios based on current share price
Navidea Biopharmaceuticals Inc, Annual Ratios
Navidea Biopharmaceuticals Inc, Annual Ratios (Cont...1)
Navidea Biopharmaceuticals Inc, Interim Ratios
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Navidea Biopharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Navidea Biopharmaceuticals Inc, Performance Chart (2013 - 2017)
Navidea Biopharmaceuticals Inc, Ratio Charts
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Syapse Inc
  • Piramal Enterprises Ltd
  • Lantern Pharma Inc
  • Ignyta Inc
  • GE Healthcare LLC
  • Eli Lilly and Co
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll